An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications

Recently the use of bioactive α-glucosidase inhibitors for the treatment of diabetes have been proven to be the most efficient remedy for controlling postprandial hyperglycemia and its detrimental physiological complications, especially in type 2 diabetes. The carbohydrate hydrolysing enzyme, α-gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Uday, Das, Abhishek Kumar, Ghosh, Sumit, Sil, Parames C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480666/
https://www.ncbi.nlm.nih.gov/pubmed/32916220
http://dx.doi.org/10.1016/j.fct.2020.111738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480666/
https://www.ncbi.nlm.nih.gov/pubmed/32916220
http://dx.doi.org/10.1016/j.fct.2020.111738

Ejemplares similares